Elise Fournier

7PUBLICATIONS
15CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsMedical biotechnology diagnostics (incl. biosensors)Nanotoxicology, health and safetyElectroanalytical chemistryGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 28, 2026
Ultra-high-sensitivity next-generation sequencing-based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort.

|Oct 24, 2025
Diagnostic relevance of SH2B3 mutations in suspected myeloid malignancies and acute leukemia: insights from a large-scale NGS-based screening study.

Leïla Ben Dhia, Mathieu Wemeau, Laurène Fenwarth

|Mar 20, 2024
Comparison of clinical outcomes of several risk stratification tools in newly diagnosed AML patients: A real-world evidence in our current therapeutic era.

Alexandre Iat, Michael Loschi, Sami Benachour

|May 23, 2022
Acute myeloid leukaemia with double minute chromosomes encompassing the 8q24 region.

Benjamin Podvin, Hélène Guermouche, Elise Fournier

|Aug 13, 2020
Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia Treatment.

Laurène Fenwarth, Elise Fournier, Meyling Cheok

|Feb 28, 2020
Baseline dysmegakaryopoiesis in inherited thrombocytopenia/platelet disorder with predisposition to haematological malignancies.

Elise Fournier, Camille Debord, Valérie Soenen

Pageof 2

Frequent Collaborators

6 joint publications

Nicolas Duployez

3 joint publications

Laurène Fenwarth

2 joint publications

Thomas Boyer

1 joint publications

Camille Debord